San Diego-based mostly Viking Therapeutics marked itself as a serious competitor while in the weight loss drug industry in February immediately after revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well a